Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PTN - Palatin Technologies Inc. -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (7)	12/6/2000 1:03:26 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 142

I know Spana's work. I think that you'll be interested in a Medline for "Spana C". He left BMY to do work for the dirty guys, Paramount/Castle. That's also Prendergast's background. Didn't know that the COO "left". He was responsible for regulatory and clinical, not a good sign given the FDA-dictated delay. That makes Quilty, O'Brien, Moussa and Putnam. So....... ex-Paramount guys are in firm control. Let's see what they can do. They'll certainly get enough options, they made sure of that. Prendergast wrote the GEN article with Blume, describing the "phenomics" applications at DGI.